PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer
<p dir="ltr">Protein Kinase D1 (PKD1) is a serine/threonine kinase encoded by the <i>PRKD1</i> gene. PKD1 has been previously shown to be a prognostic factor in ERα+ tamoxifen-resistant breast tumors and PKD1 overexpression confers estrogen independence to ERα+ MCF7 cells...
محفوظ في:
| المؤلف الرئيسي: | Caroline Spasojevic (3619418) (author) |
|---|---|
| مؤلفون آخرون: | Elisabetta Marangoni (655592) (author), Sophie Vacher (233965) (author), Franck Assayag (3157383) (author), Didier Meseure (666209) (author), Sophie Château-Joubert (11410163) (author), Martine Humbert (252271) (author), Manale Karam (3619412) (author), Jean Marc Ricort (18696934) (author), Christian Auclair (140039) (author), Marie Regairaz (1465762) (author), Ivan Bièche (3492) (author) |
| منشور في: |
2018
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer
حسب: Adviti Naik (673163)
منشور في: (2019) -
Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity
حسب: Ishita Gupta (9203073)
منشور في: (2019) -
LncRNA-Based Classification of Triple Negative Breast Cancer Revealed Inherent Tumor Heterogeneity and Vulnerabilities
حسب: Radhakrishnan Vishnubalaji (3563306)
منشور في: (2022) -
Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications
حسب: Jingxuan Shan (4711089)
منشور في: (2019) -
PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer
حسب: Reem Saleh (3513056)
منشور في: (2019)